CHRS
Coherus Oncology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.63
-0.06 ▼ -3.55%
🌙 3월 13일 7:32 PM ET (한국 3/14 08:32)
$1.65
+0.02 ▲ +1.23%
| Index | RUT | P/E | - | EPS (ttm) | -1.46 | Insider Own | 21.76% | Shs Outstand | 0.12B | Perf Week | -10.44% |
| Market Cap | 0.24B | Forward P/E | - | EPS next Y | 4.82% | Insider Trans | - | Shs Float | 0.12B | Perf Month | -20.1% |
| Enterprise Value | 0.13B | PEG | - | EPS next Q | -0.26 | Inst Own | 33.55% | Short Float | 23.58% | Perf Quarter | 22.56% |
| Income | -0.17B | P/S | 5.79 | EPS this Y | 38.21% | Inst Trans | -0.35% | Short Ratio | 12.76 | Perf Half Y | 22.56% |
| Sales | 0.04B | P/B | 3.24 | EPS next 5Y | 25.02% | ROA | -50.82% | Short Interest | 27.66M | Perf YTD | 14.79% |
| Book/sh | 0.5 | P/C | 1.42 | EPS past 3/5Y | 27.14% - | ROE | -860.65% | 52W High | -37.69% ($2.62) | Perf Year | 83.02% |
| Cash/sh | 1.15 | P/FCF | - | Sales past 3/5Y | -41.54% -38.41% | ROIC | -149.97% | 52W Low | 129.58% ($0.71) | Perf 3Y | -74.41% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -644.74% | Gross Margin | 57.94% | Volatility(W/M) | 10.45% 7.07% | Perf 5Y | -89.97% |
| Dividend TTM | - | EV/Sales | 3 | Sales Y/Y TTM | -84.2% | Oper. Margin | -424.53% | ATR (14) | 0.15 | Perf 10Y | -91.46% |
| Dividend Ex-Date | - | Quick Ratio | 1.45 | EPS Q/Q | 29.49% | Profit Margin | -403.8% | RSI (14) | 42.06 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.47 | Sales Q/Q | -76.46% | SMA20 | -4.51% ($1.71) | Beta | 1.06 | Target Price | $6.75 |
| Payout | - | Debt/Eq | 0.89 | Earnings | 3000000 | SMA50 | -9.43% ($1.8) | Rel Volume | 0.54 | Prev Close | $1.69 |
| Employees | 147 | LT Debt/Eq | 0.86 | EPS/Sales Surpr. | -9.83% -8.37% | SMA200 | 20.36% ($1.35) | Avg Volume(3M) | 2.17M | Price | $1.63 |
| IPO | 2014/11/6 | Option/Short | Yes/Yes | Trades | 3031 | Volume | 1,164,578 | Change | -3.55% |
뉴스 로딩 중...